
Ginsenoside Rb3
CAS No. 68406-26-8
Ginsenoside Rb3 ( Ginsenoside C, Ginsenoside-Rb3, HY-N0041, HYN0041 )
产品货号. M18996 CAS No. 68406-26-8
Ginsenoside Rb3 是一种天然三萜皂苷,对 TNFα 诱导的 NF-κB 转录活性具有抑制作用。它还抑制 COX-2 和 iNOS mRNA 的诱导。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥243 | 有现货 |
![]() ![]() |
10MG | ¥446 | 有现货 |
![]() ![]() |
25MG | ¥737 | 有现货 |
![]() ![]() |
50MG | ¥1077 | 有现货 |
![]() ![]() |
100MG | ¥1596 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Ginsenoside Rb3
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Ginsenoside Rb3 是一种天然三萜皂苷,对 TNFα 诱导的 NF-κB 转录活性具有抑制作用。它还抑制 COX-2 和 iNOS mRNA 的诱导。
-
产品描述Ginsenoside Rb3 is found in species of Panax. It inhibits contractions in aortic rings, decreases blood glucose levels, and improves oral glucose tolerance, improves immobility time in the forced swim tail suspension, and learned helplessness tests, and inhibits oxidative damage.
-
体外实验——
-
体内实验——
-
同义词Ginsenoside C, Ginsenoside-Rb3, HY-N0041, HYN0041
-
通路Metabolic Enzyme/Protease
-
靶点P450
-
受体Others
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number68406-26-8
-
分子量1079.2
-
分子式C53H90O22
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 100 mg/mL (92.66 mM)
-
SMILESO([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO[C@H]1[C@H](O)[C@@H](O)[C@H](O)CO1)[C@]([C@H]1CC[C@]2([C@@]3(CC[C@H]4C([C@H](CC[C@@]4([C@H]3C[C@H]([C@H]12)O)C)O[C@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@H](O2)CO)[C@@H](O)[C@H](O)[C@H](O1)CO)(C)C)C)C)(CCC=C(C)C)C
-
化学全称(2S,3R,4S,5S,6R)-2-(((2R,3R,4S,5S,6R)-4,5-dihydroxy-2-(((3S,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-((S)-6-methyl-2-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)hept-5-en-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Ma L, et al. Ginsenoside Rb3 protects cardiomyocytes against ischemia-reperfusion injury via the inhibition of JNK-mediated NF-κB pathway: a mouse cardiomyocyte model. PLoS One. 2014 Aug 1;9(8):e103628.